Correlation Between Snap and Vivoryon Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Snap and Vivoryon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Snap and Vivoryon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Snap Inc and Vivoryon Therapeutics NV, you can compare the effects of market volatilities on Snap and Vivoryon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Snap with a short position of Vivoryon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Snap and Vivoryon Therapeutics.

Diversification Opportunities for Snap and Vivoryon Therapeutics

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Snap and Vivoryon is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Snap Inc and Vivoryon Therapeutics NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivoryon Therapeutics and Snap is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Snap Inc are associated (or correlated) with Vivoryon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivoryon Therapeutics has no effect on the direction of Snap i.e., Snap and Vivoryon Therapeutics go up and down completely randomly.

Pair Corralation between Snap and Vivoryon Therapeutics

Given the investment horizon of 90 days Snap Inc is expected to generate 1.8 times more return on investment than Vivoryon Therapeutics. However, Snap is 1.8 times more volatile than Vivoryon Therapeutics NV. It trades about -0.11 of its potential returns per unit of risk. Vivoryon Therapeutics NV is currently generating about -0.47 per unit of risk. If you would invest  1,262  in Snap Inc on August 31, 2024 and sell it today you would lose (101.00) from holding Snap Inc or give up 8.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Snap Inc  vs.  Vivoryon Therapeutics NV

 Performance 
       Timeline  
Snap Inc 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Snap Inc are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Snap reported solid returns over the last few months and may actually be approaching a breakup point.
Vivoryon Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vivoryon Therapeutics NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Vivoryon Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Snap and Vivoryon Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Snap and Vivoryon Therapeutics

The main advantage of trading using opposite Snap and Vivoryon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Snap position performs unexpectedly, Vivoryon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivoryon Therapeutics will offset losses from the drop in Vivoryon Therapeutics' long position.
The idea behind Snap Inc and Vivoryon Therapeutics NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Transaction History
View history of all your transactions and understand their impact on performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals